Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis
- C. LahiffAffiliated withDepartment of Medicine, St. Columcilles Hospital
- , O. B. KhiaronAffiliated withDepartment of Medicine, St. Columcilles Hospital
- , N. NolanAffiliated withDepartment of Pathology, St. Columcilles Hospital
- , G. A. ChadwickAffiliated withDepartment of Medicine, St. Columcilles Hospital Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Pneumocystis carinii pneumonia (PCP) is a rare form of pneumonia associated with immune-suppression. It is common in patients with AIDS and with a CD4 count of less than 200 cells/mm3. We report a case of PCP secondary to immune-suppression in a 41-year-old man with psoriatic arthritis being treated with the immune-modulatory agent etanercept.
Diagnosis of PCP was made histologically using tissue obtained via transbronchial biopsy.
There was a good response to standard treatment with high-dose co-trimoxazole.
This report highlights a recognised but previously unreported complication of etanercept.
KeywordsPneumocystis carinii Etanercept Psoriatic arthritis Grocott’s silver stain Co-trimoxazole
- Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis
Irish Journal of Medical Science
Volume 176, Issue 4 , pp 309-311
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Pneumocystis carinii
- Psoriatic arthritis
- Grocott’s silver stain
- Industry Sectors